← Back to patent-cliff list
ECC-4703
Tier C — Watch / tradeECC-4703
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：THRB
Indications (approved)：Obesity, 体重, Non-alcoholic steatohepatitis, Dyslipidaemia
Regional status
US
Phase II
2025-12-15
EU
-
China
Phase I
2023-05-02
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of ECC-4703?
Approved indications include: Obesity, 体重, Non-alcoholic steatohepatitis, Dyslipidaemia.
When does the ECC-4703 patent expire?
No public expiry year is available for ECC-4703 yet; this page updates once verified.
How do I get a quote for ECC-4703 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29